Small molecule probes for the specific imaging of monoamine oxidase A and monoamine oxidase B

Hare MLC. Tyramine oxidase: a new enzyme system in liver. Biochem J. 1928;22(4):968–79. https://doi.org/10.1042/bj0220968

Manzoor S, Hoda N. A comprehensive review of monoamine oxidase inhibitors as anti‐Alzheimer’s disease agents: a review. Eur J Med Chem. 2020;206:112787. https://doi.org/10.1016/j.ejmech.2020.112787

Ramsay RR, Albreht A. Kinetics, mechanism, and inhibition of monoamine oxidase. J Neural Transm. 2018;125(11):1659–83. https://doi.org/10.1007/s00702-018-1861-9

Santin Y, Resta J, Parini A, Mialet‐Perez J. Monoamine oxidases in age‐associated diseases: new perspectives for old enzymes. Ageing Res Rev. 2021;66:101256. https://doi.org/10.1016/j.arr.2021.101256

Yu J, Gao B. Molecular imaging for cancer immunotherapy. iRADIOLOGY. 2023;1(1):3–17. https://doi.org/10.1002/ird3.12

Meyer JH, Braga J. Development and clinical application of positron emission tomography imaging agents for monoamine oxidase B. Front Neurosci. 2022;15:773404. https://doi.org/10.3389/fnins.2021.773404

Jian C, Yan J, Zhang H, Zhu J. Recent advances of small molecule fluorescent probes for distinguishing monoamine oxidase‐A and monoamine oxidase‐B in vitro and in vivo. Mol Cell Probes. 2021;55:101686. https://doi.org/10.1016/j.mcp.2020.101686

Rong J, Haider A, Jeppesen TE, Josephson L, Liang SH. Radiochemistry for positron emission tomography. Nat Commun. 2023;14(1):3257. https://doi.org/10.1038/s41467-023-36377-4

Zimmer L. Positron emission tomography for the discovery of new drugs in psychiatry. ACS Chem Neurosci. 2023;14(4):524–6. https://doi.org/10.1021/acschemneuro.3c00036

Ritt P. Recent developments in SPECT/CT. Semin Nucl Med. 2022;52(3):276–85. https://doi.org/10.1053/j.semnuclmed.2022.01.004

Rando RR. Mechanism‐based enzyme inactivators. Pharmacol Rev. 1984;36(2):111–42. https://doi.org/10.1016/0076-6879(95)49038-8

MacGregor RR, Halldin C, Fowler JS, Wolf AP, Arnett CD, Langström B, et al. Selective, irreversible in vivo binding of [¹¹C]clorgyline and [¹¹C]‐L‐deprenyl in mice: potential for measurement of functional monoamine oxidase activity in brain using positron emission tomography. Biochem Pharmacol. 1985;34(17):3207–10. https://doi.org/10.1016/0006-2952(85)90173-x

Fowler JS, MacGregor RR, Wolf AP, Arnett CD, Dewey SL, Schlyer D, et al. Mapping human brain monoamine oxidase A and B with ¹¹C‐labeled suicide inactivators and PET. Science. 1987;235(4787):481–5. https://doi.org/10.1126/science.3099392

Gulyás B, Pavlova E, Kása P, Gulya K, Bakota L, Várszegi S, et al. Activated MAO‐B in the brain of Alzheimer patients, demonstrated by [¹¹C]‐L‐deprenyl using whole hemisphere autoradiography. Neurochem Int. 2011;58(1):60–8. https://doi.org/10.1016/j.neuint.2010.10.013

Fowler JS, Logan J, Ding Y.‐S, Franceschi D, Wang G.‐J, Volkow ND, et al. Non‐MAO A binding of clorgyline in white matter in human brain. J Neurochem. 2008;79(5):1039–46. https://doi.org/10.1046/j.1471-4159.2001.00649.x

Nag S, Varrone A, Tóth M, Thiele A, Kettschau G, Heinrich T, et al. In vivo evaluation in cynomolgus monkey brain and metabolism of [¹⁸F]fluorodeprenyl: a new MAO‐B pet radioligand. Synapse. 2012;66(4):323–30. https://doi.org/10.1002/syn.21514

Nag S, Lehmann L, Kettschau G, Heinrich T, Thiele A, Varrone A, et al. Synthesis and evaluation of [¹⁸F]fluororasagiline, a novel positron emission tomography (PET) radioligand for monoamine oxidase B (MAO‐B). Bioorg Med Chem. 2012;20(9):3065–71. https://doi.org/10.1016/j.bmc.2012.02.056

Nag S, Lehmann L, Kettschau G, Toth M, Heinrich T, Thiele A, et al. Development of a novel fluorine‐18 labeled deuterated fluororasagiline ([18F]fluororasagiline‐D2) radioligand for PET studies of monoamino oxidase B (MAO‐B). Bioorg Med Chem. 2013;21(21):6634–41. https://doi.org/10.1016/j.bmc.2013.08.019

Fowler JS, Wang G.‐J, Logan J, Xie S, Volkow ND, MacGregor RR, et al. Selective reduction of radiotracer trapping by deuterium substitution: comparison of carbon‐11‐L‐deprenyl and carbon‐11‐deprenyl‐D2 for MAO B mapping. J Nucl Med. 1995;36(7):1255–62.

Fowler JS, Volkow ND, Wang GJ, Pappas N, Logan J, MacGregor R, et al. Neuropharmacological actions of cigarette smoke. J Addict Dis. 1998;17(1):23–34. https://doi.org/10.1300/J069v17n01_03

Fowler JS, Wang GJ, Volkow ND, Franceschi D, Logan J, Pappas N, et al. Smoking a single cigarette does not produce a measurable reduction in brain MAO B in non‐smokers. Nicotine Tob Res. 1999;1(4):325–9. https://doi.org/10.1080/14622299050011451

Carter SF, Schoell M, Almkvist O, Wall A, Engler H, Långström B, et al. Evidence for astrocytosis in prodromal Alzheimer disease provided by ¹¹C‐deuterium‐L‐deprenyl: a multitracer PET paradigm combining ¹¹C‐Pittsburgh compound B and ¹⁸F‐FDG. J Nucl Med. 2012;53(1):37–46. https://doi.org/10.2967/jnumed.110.087031

Nag S, Lehmann L, Heinrich T, Thiele A, Kettschau G, Nakao R, et al. Synthesis of three novel fluorine‐18 labelled analogues of L‐deprenyl for positron emission tomography (PET) studies of monoamine oxidase B (MAO‐B). J Med Chem. 2011;54(20):7023–9. https://doi.org/10.1021/jm200710b

Nag S, Fazio P, Lehmann L, Kettschau G, Heinrich T, Thiele A, et al. In vivo and in vitro characterization of a novel MAO‐B inhibitor radioligand, ¹⁸F‐Labeled deuterated fluorodeprenyl. J Nucl Med. 2016;57(2):315–20. https://doi.org/10.2967/jnumed.115.161083

Ametamey SM, Beer H.‐F, Guenther I, Antonini A, Leenders KL, Waldmeier PC, et al. Radiosynthesis of [¹¹C]brofaromine, a potential tracer for imaging monoamine oxidase A. Nucl Med Biol. 1996;23(3):229–34. https://doi.org/10.1016/0969-8051(95)02051-9

Bergström M, Westerberg G, Långström B. ¹¹C‐harmine as a tracer for monoamine oxidase A (MAO‐A): In vitro and in vivo studies. Nucl Med Biol. 1997;24(4):287–93. https://doi.org/10.1016/s0969-8051(97)00013-9

Goller L, Bergström M, Nilsson S, Westerberg G, Långström B. MAO‐A enzyme binding in bladder‐cancer characterized with [C‐11]‐harmine in frozen‐section autoradiography. Oncol Rep. 1995;2(5):717–21. https://doi.org/10.3892/or.2.5.717

Örlefors H, Sundin A, Fasth K.‐J, Öberg K, Långström B, Eriksson B, et al. Demonstration of high monoaminoxidase‐A levels in neuroendocrine gastroenteropancreatic tumors in vitro and in vivo‐tumor visualization using positron emission tomography with ¹¹C‐harmine. Nucl Med Biol. 2003;30(6):669–79. https://doi.org/10.1016/S0969-8051(03)00034-9

Herlin G, Persson B, Bergström M, Långström B, Aspelin P. ¹¹C‐harmine as a potential PET tracer for ductal pancreas cancer: in vitro studies. Eur Radiol. 2003;13(4):729–33. https://doi.org/10.1007/s00330-002-1443-x

Zirbesegger K, Reyes L, Paolino A, Dapueto R, Arredondo F, Gambini JP, et al. Molecular imaging of monoamine oxidase A expression in highly aggressive prostate cancer: synthesis and preclinical evaluation of positron emission tomography tracers. ACS Pharmacol Transl Sci. 2023;6(11):1734–44. https://doi.org/10.1021/acsptsci.3c00175

Schieferstein H, Piel M, Beyerlein F, Lüddens H, Bausbacher N, Buchholz HG, et al. Selective binding to monoamine oxidase A: in vitro and in vivo evaluation of (18)F‐labeled β‐carboline derivatives. Bioorg Med Chem. 2015;23(3):612–23. https://doi.org/10.1016/j.bmc.2014.11.040

Saba W, Valette H, Peyronneau M.‐A, Bramoullé Y, Coulon C, Curet O, et al. [¹¹C]SL25.1188, a new reversible radioligand to study the monoamine oxidase type B with PET: preclinical characterisation in nonhuman primate. Synapse. 2010;64(1):61–9. https://doi.org/10.1002/syn.20703

Dahl K, Bernard‐Gauthier V, Nag S, Varnäs K, Narayanaswami V, Mahdi Moein M, et al. Synthesis and preclinical evaluation of [¹⁸F]FSL25.1188, a reversible PET radioligand for monoamine oxidase‐B. Bioorg Med Chem Lett. 2019;29(13):1624–7. https://doi.org/10.1016/j.bmcl.2019.04.040

Harada R, Hayakawa Y, Ezura M, Lerdsirisuk P, Du Y, Ishikawa Y, et al. ¹⁸F‐SMBT‐1: a selective and reversible PET tracer for monoamine oxidase‐B imaging. J Nucl Med. 2021;62(2):253–8. https://doi.org/10.2967/jnumed.120.244400

Villemagne VL, Harada R, Doré V, Furumoto S, Mulligan R, Kudo Y, et al. Assessing reactive astrogliosis with ¹⁸F‐SMBT‐1 across the Alzheimer disease spectrum. J Nucl Med. 2022;63(10):1560–9. https://doi.org/10.2967/jnumed.121.263255

Bottlaender M, Dollé F, Guenther I, Roumenov D, Fuseau C, Bramoulle Y, et al. Mapping the cerebral monoamine oxidase type A: positron emission tomography characterization of the reversible selective inhibitor [¹¹C]befloxatone. J Pharmacol Exp Ther. 2003;305(2):467–73. https://doi.org/10.1124/jpet.102.046953

Zanotti‐Fregonara P, Leroy C, Roumenov D, Trichard C, Martinot J.‐L, Bottlaender M. Kinetic analysis of [¹¹C]befloxatone in the human brain, a selective radioligand to image monoamine oxidase A. EJNMMI Res. 2013;3(1):78. https://doi.org/10.1186/2191-219X-3-78

Jensen SB, Di Santo R, Olsen AK, Pedersen K, Costi R, Cirilli R, et al. Synthesis and cerebral uptake of 1‐(1‐[¹¹C]methyl‐1H‐pyrrol‐2‐yl)‐2‐phenyl‐2‐(1‐pyrrolidinyl)ethanone, a novel tracer for positron emission tomography studies of monoamine oxidase type A. J Med Chem. 2008;51(6):1617–22. https://doi.org/10.1021/jm701378e

Maschauer S, Haller A, Riss PJ, Kuwert T, Prante O, Cumming P. Specific binding of [(18)F]fluoroethyl‐harmol to monoamine oxidase A in rat brain cryostat sections, and compartmental analysis of binding in living brain. J Neurochem. 2015;135(5):908–17. https://doi.org/10.1111/jnc.13370

Beer H.‐F, Rossetti I, Frey LD, Hasler PH, Schubiger PA. ¹²³I‐Labeling and evaluation of Ro 43‐0463, a SPET tracer for MAO‐B imaging. Nucl Med Biol. 1995;22(7):929–36. https://doi.org/10.1016/0969-8051(95)00041-u

Bläuenstein P, Rémy N, Buck A, Ametamey S, Häberli M, Schubiger PA. In vivo properties of N‐(2‐aminoethyl)‐5‐halogeno‐2‐pyridinecarboxamide ¹⁸F‐ and ¹²³I‐labelled reversible inhibitors of monoamine oxidase B. Nucl Med Biol. 1998;25(1):47–52. https://doi.org/10.1016/s0969-8051(97)00143-1

Hirata M, Kagawa S, Yoshimoto M, Ohmomo Y. Synthesis and characterization of radioiodinated MD‐230254: a new ligand for potential imaging of monoamine oxidase B activity by single photon emission computed tomography. Chem Pharm Bull. 2002;50(5):609–14. https://doi.org/10.1248/cpb.50.609

Bernard S, Fuseau C, Schmid L, Milcent R, Crouzel C. Synthesis and in vivo studies of a specific monoamine oxidase B inhibitor: 5‐[4‐(benzyloxy)phenyl]‐3‐(2‐cyanoethyl)‐1,3,4‐oxadiazol‐[¹¹C]‐2(3H)‐one. Eur J Nucl Med. 1996;23(2):150–6. https://doi.org/10.1007/bf01731838

Yoshimoto M, Hirata M, Kagawa S, Magata Y, Ohmomo Y, Temma T. Synthesis and characterization of novel radiofluorinated probes for Positron Emission Tomography imaging of monoamine oxidase B. J Label Compd Radiopharm. 2019;62(9):580–7. https://doi.org/10.1002/jlcr.3779

Bramoullé Y, Puech F, Saba W, Valette H, Bottlaender M, George P, et al. Radiosynthesis of (S)‐5‐methoxymethyl‐3‐[6‐(4,4,4‐trifluorobutoxy)benzo[d]isoxazol‐3‐yl]oxazolidin‐2‐[¹¹C]one ([11C]SL25.1188), a novel radioligand for imaging monoamine oxidase‐B with PET. J Label Compd Radiopharm. 2008;51(3):153–8. https://doi.org/10.1002/jlcr.1492

Vasdev N, Sadovski O, Garcia A, Dollé F, Meyer JH, Houle S, et al. Radiosynthesis of [¹¹C]SL25.1188 via [¹¹C]CO₂ fixation for imaging monoamine oxidase B. J Label Compd Radiopharm. 2011;54(10):678–80. https://doi.org/10.1002/jlcr.1908

Moriguchi S, Wilson AA, Miler L, Rusjan PM, Vasdev N, Kish SJ, et al. Monoamine oxidase B total distribution volume in the prefrontal cortex of major depressive disorder: an [¹¹C]SL25.1188 positron emission tomography study. JAMA Psychiat. 2019;76(6):634–41. https://doi.org/10.1001/jamapsychiatry.2019.0044

Hicks JW, Sadovski O, Parkes J, Houle S, Hay BA, Carter RL, et al. Radiosynthesis and ex vivo evaluation of [¹⁸F]‐(S)‐3‐(6‐(3‐fluoropropoxy)benzo[d]isoxazol‐3‐yl)‐5‐(methoxymethyl)oxazolidin‐2‐one for imaging MAO‐B with PET. Bioorg Med Chem Lett. 2015;25(2):288–91. https://doi.org/10.1016/j.bmcl.2014.11.048

Villemagne VL, Harada R, Doré V, Furumoto S, Mulligan R, Kudo Y, et al. First‐in‐humans evaluation of ¹⁸F‐SMBT‐1, a novel ¹⁸F‐labeled monoamine oxidase‐B PET tracer for imaging reactive astrogliosis. J Nucl Med. 2022;63(10):1551–9. https://doi.org/10.2967/jnumed.121.263254

Dukić‐Stefanović S, Lai TH, Toussaint M, Clauß O, Jevtić II, Penjišević JZ, et al. In vitro and in vivo evaluation of fluorinated indanone derivatives as potential positron emission tomography agents for the imaging of monoamine oxidase B in the brain. Bioorg Med Chem Lett. 2021;48:128254. https://doi.org/10.1016/j.bmcl.2021.128254

Xu Y, Cen P, Ma L, Tian M, Zhang X, Zhang Q, et al. Highly efficient radiosynthesis and biological evaluation of [¹⁸F]safinamide, a radiolabelled anti‐Parkinsonian drug for positron emission tomography imaging. ChemMedChem. 2022;17(20):e202200472. https://doi.org/10.1002/cmdc.202200472

Moerlein SM, Stöcklin G, Pawlik G, Wienhard K, Heiss W.‐D. Regional cerebral pharmacokinetics of the dopaminergic neurotoxin 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine as examined by positron emission tomography in a baboon is altered by tranylcypromine. Neurosci Lett. 1986;66(2):205–9. https://doi.org/10.1016/0304-3940(86)90191-6

Brooks AF, Shao X, Quesada CA, Sherman P, Scott PJH, Kilbourn MR. In vivo metabolic trapping radiotracers for imaging monoamine oxidase‐A and ‐B enzymatic activity. ACS Chem Neurosci. 2015;6(12):1965–71. https://doi.org/10.1021/acschemneuro.5b00223

Shinotoh H, Inoue O, Suzuki K, Yamasaki T, Iyo M, Hashimoto K, et al. Kinetics of [¹¹C]N,N‐dimethylphenylethylamine in mice and humans: potential for measurement of brain MAO‐B activity. J Nucl Med. 1987;28(6):1006–11. https://jnm.snmjournals.org/content/28/6/1006

Zhang J, Chai X, He X.‐P, Kim H.‐J, Yoon J, Tian H. Fluorogenic probes for disease‐relevant enzymes. Chem Soc Rev. 2019;48(2):683–722. https://doi.org/10.1039/C7CS00907K

Wang K, Liu C, Zhu H, Zhang Y, Su M, Wang X, et al. Recent advances in small‐molecule fluorescent probes for diagnosis of cancer cells/tissues. Coordin Chem Rev. 2023;477:214946. https://doi.org/10.1016/j.ccr.2022.214946

Wang X, Li Y, Wang J. Research progress of fluorescent probes for monoamine oxidases. Chin J Lumin. 2021;42(7):938–52. https://doi.org/10.37188/CJL.20210086

Zhou J, Geng Y, Wang Z. Fluorescent molecular probes for imaging and detection of oxidases and peroxidases in biological samples. Methods. 2023;210:20–35. https://doi.org/10.1016/j.ymeth.2023.01.002

Huang J, Hong D, Lang W, Liu J, Dong J, Yuan C, et al. Recent advances in reaction‐based fluorescent probes for detecting monoamine oxidases in living systems. Analyst. 2019;144(12):3703–9. https://doi.org/10.1039/c9an00409b

Wu JB, Lin T.‐P, Gallagher JD, Kushal S, Chung LWK, Zhau HE, et al. Monoamine oxidase A inhibitor–near‐infrared dye conjugate reduces prostate tumor growth. J Am Chem Soc. 2015;137(6):2366–74. https://doi.org/10.1021/ja512613j

Kim WY, Won M, Salimi A, Sharma A, Lim JH, Kwon SH, et al. Monoamine Oxidase‐A targeting probe for prostate cancer imaging and inhibition of metastasis. Chem Comm. 2019;55(88):13267–70. https://doi.org/10.1039/c9cc07009e

Krysiak JM, Kreuzer J, Macheroux P, Hermetter A, Sieber SA, Breinbauer R. Activity‐based probes for studying the activity of flavin‐dependent oxidases and for the protein target profiling of monoamine oxidase inhibitors. Angew Chem Int Ed. 2012;51(28):7035–40. https://doi.org/10.1002/anie.201201955

Li L, Zhang C.‐W, Ge J, Qian L, Chai B.‐H, Zhu Q, et al. A small‐molecule probe for selective profiling and imaging of monoamine oxidase B activities in models of Parkinson’s disease. Angew Chem Int Ed. 2015;54(37):10821–5. https://doi.org/10.1002/anie.201504441

Aljanabi R, Alsous L, Sabbah DA, Gul HI, Gul M, Bardaweel SK. Monoamine oxidase (MAO) as a potential target for anticancer drug design and development. Molecules. 2021;26(19):6019. https://doi.org/10.3390/molecules26196019

Chen C.‐H, Wu BJ. Monoamine oxidase A: an emerging therapeutic target in prostate cancer. Front Oncol. 2023;13:1137050. https://doi.org/10.3389/fonc.2023.1137050

Irwin RW, Escobedo AR, Shih JC. Near‐infrared monoamine oxidase inhibitor biodistribution in a glioma mouse model. Pharm Res. 2021;38(3):461–71. https://doi.org/10.1007/s11095-021-03012-0

Zhao J, Ma T, Chang B, Fang J. Recent progress on NIR fluorescent probes for enzymes. Molecules. 2022;27(18):5922. https://doi.org/10.3390/molecules27185922

Meng X, Pang X, Zhang K, Gong C, Yang J, Dong H, et al. Recent advances in near‐infrared‐II fluorescence imaging for deep‐tissue molecular analysis and cancer diagnosis. Small. 2022;18(31):e2202035. https://doi.org/10.1002/smll.202202035

Chen D, Qin W, Fang H, Wang L, Peng B, Li L, et al. Recent progress in two‐photon small molecule fluorescent probes for enzymes. Chin Chem Lett. 2019;30(10):1738–44. https://doi.org/10.1016/j.cclet.2019.08.001

Jin H, Yang M, Sun Z, Gui R. Ratiometric two‐photon fluorescence probes for sensing, imaging and biomedicine applications at living cell and small animal levels. Coordin Chem Rev. 2021;446:214114. https://doi.org/10.1016/j.ccr.2021.214114

Wu X, Wang R, Kwon N, Ma H, Yoon J. Activatable fluorescent probes for in situ imaging of enzymes. Chem Soc Rev. 2022;51(2):450–63. https://doi.org/10.1039/D1CS00543J

Lu S.‐B, Wei L, He W, Bi Z.‐Y, Qian Y, Wang J, et al. Recent advances in the enzyme‐activatable organic fluorescent probes for tumor imaging and therapy. ChemistryOpen. 2022;11(10):e202200137. https://doi.org/10.1002/open.202200137

Fan J, Hu M, Zhan P, Peng X. Energy transfer cassettes based on organic fluorophores: construction and applications in ratiometric sensing. Chem Soc Rev. 2013;42(1):29–43. https://doi.org/10.1039/c2cs35273g

Wu X, Li L, Shi W, Gong Q, Li X, Ma H. Sensitive and selective ratiometric fluorescence probes for detection of intracellular endogenous monoamine oxidase A. Anal Chem. 2016;88(2):1440–6. https://doi.org/10.1021/acs.analchem.5b04303

Meng Z, Yang L, Yao C, Li H, Fu Y, Wang K, et al. Development of a naphthlimide‐based fluorescent probe for imaging monoamine oxidase A in living cells and zebrafish. Dyes Pigments. 2020;176:108208. https://doi.org/10.1016/j.dyepig.2020.108208

Fang H, Zhang H, Li L, Ni Y, Shi R, Li Z, et al. Rational design of two‐photon fluorogenic probe for visualizing monoamine oxidase A activity in human glioma tissues. Angew Chem Int Ed. 2020;59(19):7536–41. https://doi.org/10.1002/anie.202000059

Hu Y, Yin S.‐Y, Liu W, Li Z, Chen Y, Li J. Rationally designed monoamine oxidase A‐activatable AIE molecular photosensitizer for the specific imaging and cellular therapy of tumors. Aggregate. 2023;4(2):e256. https://doi.org/10.1002/agt2.256

Yang Z.‐M, Mo Q.‐Y, He J.‐M, Mo D.‐L, Li J, Chen H, et al. Mitochondrial‐targeted and near‐infrared fluorescence probe for bioimaging and evaluating monoamine oxidase A activity in hepatic fibrosis. ACS Sens. 2020;5(4):943–51. https://doi.org/10.1021/acssensors.9b02116

Li X, Shi D, Song Y, Xu Y, Gao Y, Qiu W, et al. Specific tracking of monoamine oxidase A in heart failure models by a far‐red fluorescent probe with an ultra large Stokes shift. Chin Chem Lett. 2022;33(3):1572–6. https://doi.org/10.1016/j.cclet.2021.08.114

Shu Y, Liu Y, Gao Y, Li J. pH‐Triggered mitochondria targeting fluorescent probe for detecting monoamine oxidases A in living cells. Sensor Actuat B Chem. 2023;390:133912. https://doi.org/10.1016/j.snb.2023.133912

Mei Y, Liu Z, Liu M, Gong J, He X, Zhang Q.‐W, et al. Two‐photon fluorescence imaging and ratiometric quantification of mitochondrial monoamine oxidase‐A in neurons. Chem Commun. 2022;58(46):6657–60. https://doi.org/10.1039/d2cc01909d

Fang H, Shi R, Chen D, Qu Y, Wu Q, Yang X, et al. Intramolecular charge transfer enhancing strategy based MAO‐A specific two‐photon fluorescent probes for glioma cell/tissue imaging. Chem Commun. 2021;57(85):11260–3. https://doi.org/10.1039/d1cc04744b

Fang H, Li P, Shen C, Tang F, Ding A, Bai H, et al. A fluorogenic‐inhibitor‐based probe for profiling and imaging of monoamine oxidase A in live human glioma cells and clinical tissues. Sci China Chem. 2023;66(7):2053–61. https://doi.org/10.1007/s11426-023-1602-7

Wu J, Han C, Cao X, Lv Z, Wang C, Huo X, et al. Mitochondria targeting fluorescent probe for MAO‐A and the application in the development of drug candidate for neuroinflammation. Anal Chim Acta. 2022;1199:339573. https://doi.org/10.1016/j.aca.2022.339573

Wu X, Shi W, Li X, Ma H. A strategy for specific fluorescence imaging of monoamine oxidase A in living cells. Angew Chem Int Ed. 2017;56(48):15319–23. https://doi.org/10.1002/anie.201708428

Yang Z, Li W, Chen H, Mo Q, Li J, Zhao S, et al. Inhibitor structure‐guided design and synthesis of near‐infrared fluorescent probe for Monoamine Oxidase A (MAO‐A) and its application in living cells and in vivo. Chem Commun. 2019;55(17):2477–80. https://doi.org/10.1039/C8CC10084E

Shang J, Shi W, Li X, Ma H. Water‐soluble near‐infrared fluorescent probes for specific detection of monoamine oxidase A in living biosystems. Anal Chem. 2021;93(9):4285–90. https://doi.org/10.1021/acs.analchem.0c05283

Kaludercic N, Takimoto E, Nagayama T, Feng N, Lai EW, Bedja D, et al. Monoamine Oxidase A‐mediated enhanced catabolism of norepinephrine contributes to adverse remodeling and pump failure in hearts with pressure overload. Circ Res. 2010;106(1):193–202. https://doi.org/10.1161/circresaha.109.198366

Kaludercic N, Carpi A, Menabò R, Di Lisa F, Paolocci N. Monoamine oxidases (MAO) in the pathogenesis of heart failure and ischemia/reperfusion injury. BBA Mol Cell Res. 2011;1813(7):1323–32. https://doi.org/10.1016/j.bbamcr.2010.09.010

Long S, Chen L, Xiang Y, Song M, Zheng Y, Zhu Q. An activity‐based fluorogenic probe for sensitive and selective monoamine oxidase‐B detection. Chem Commun. 2012;48(57):7164–6. https://doi.org/10.1039/C2CC33089J

Xiang Y, He B, Li X, Zhu Q. The design and synthesis of novel ‘‘turn‐on’’ fluorescent probes to visualize monoamine oxidase‐B in living cells. RSC Adv. 2013;3(15):4876–9. https://doi.org/10.1039/C3RA22789H

Qin H, Li L, Li K, Yu X. Novel strategy of constructing fluorescent probe for MAO‐B via cascade reaction and its application in imaging MAO‐B in human astrocyte. Chin Chem Lett. 2019;30(1):71–4. https://doi.org/10.1016/j.cclet.2018.05.018

Li L, Zhang C.‐W, Chen GYJ, Zhu B, Chai C, Xu Q.‐H, et al. A sensitive two‐photon probe to selectively detect monoamine oxidase B activity in Parkinson’s disease models. Nat Commun. 2014;5(1):3276. https://doi.org/10.1038/ncomms4276

Fan N, Wu C, Zhou Y, Wang X, Li P, Liu Z, et al. Rapid two‐photon fluorescence imaging of monoamine oxidase B for diagnosis of early‐stage liver fibrosis in mice. Anal Chem. 2021;93(18):7110–7. https://doi.org/10.1021/acs.analchem.1c00815

Zhang Y, Wang J, Yi W, Tiemuer A, Yu H, Liu Y, et al. Activatable organic upconversion nanoprobe for bioimaging of monoamine oxidase B in Parkinson’s disease. Sensor Actuat B Chem. 2023;389:133880. https://doi.org/10.1016/j.snb.2023.133880

Wang X, Song X, Li P, Sun S, Mao J, Liu S, et al. Fluorescence method for monoamine oxidase B detection based on the cage function of glyoxal and phenethylamine on G‐rich DNA. Sensor Actuat B Chem. 2022;372:132624. https://doi.org/10.1016/j.snb.2022.132624

Wang R, Han X, You J, Yu F, Chen L. Ratiometric near‐infrared fluorescent probe for synergistic detection of monoamine oxidase B and its contribution to oxidative stress in cell and mice aging models. Anal Chem. 2018;90(6):4054–61. https://doi.org/10.1021/acs.analchem.7b05297

Cho A. Clever math enables MRI to map biomolecules. Science. 2019;363(6433):1263. https://doi.org/10.1126/science.363.6433.1263

Li A, Luo X, Chen D, Li L, Lin H, Gao J. Small molecule probes for ¹⁹F magnetic resonance imaging. Anal Chem. 2023;95(1):70–82. https://doi.org/10.1021/acs.analchem.2c04539

Yamaguchi K, Ueki R, Nonaka H, Sugihara F, Matsuda T, Sando S. Design of chemical shift‐switching ¹⁹F magnetic resonance imaging probe for specific detection of human monoamine oxidase A. J Am Chem Soc. 2011;133(36):14208–11. https://doi.org/10.1021/ja2057506

Ma X, Mao M, He J, Liang C, Xie H.‐Y. Nanoprobe‐based molecular imaging for tumor stratification. Chem Soc Rev. 2023;52(18):6447–96. https://doi.org/10.1039/d3cs00063j

Yang Y, Yue S, Qiao Y, Zhang P, Jiang N, Ning Z, et al. Activable multi‐modal nanoprobes for imaging diagnosis and therapy of tumors. Front Chem. 2021;8:572471. https://doi.org/10.3389/fchem.2020.572471

Liu H, Wang R, Gao H, Chen L, Li X, Yu X, et al. Nanoprobes for PET/MR imaging. Adv Therap. 2023;7(2):2300232. https://doi.org/10.1002/adtp.202300232